John F. Neylan - Net Worth and Insider Trading

John F. Neylan Net Worth

The estimated net worth of John F. Neylan is at least $533,357 dollars as of 2024-04-24. John F. Neylan is the Chief Medical Officer of Keryx Biopharmaceuticals Inc and owns about 148,279 shares of Keryx Biopharmaceuticals Inc (KERX) stock worth over $498,217. John F. Neylan is also the See Remarks of Angion Biomedica Corp and owns about 3,514 shares of Angion Biomedica Corp (ANGN) stock worth over $35,140. Details can be seen in John F. Neylan's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that John F. Neylan has not made any transactions after 2021-12-20 and currently still holds the listed stock(s).

Transaction Summary of John F. Neylan

To

John F. Neylan Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, John F. Neylan owns 2 companies in total, including Angion Biomedica Corp (ANGN) , and Elicio Therapeutics Inc (ELTX) .

Click here to see the complete history of John F. Neylan’s form 4 insider trades.

Insider Ownership Summary of John F. Neylan

Ticker Comapny Transaction Date Type of Owner
ANGN Angion Biomedica Corp 2021-12-20 See Remarks
ELTX Elicio Therapeutics Inc 2021-02-04 See Remarks

John F. Neylan Latest Holdings Summary

John F. Neylan currently owns a total of 2 stocks. Among these stocks, John F. Neylan owns 148,279 shares of Keryx Biopharmaceuticals Inc (KERX) as of November 15, 2018, with a value of $498,217 and a weighting of 93.41%. John F. Neylan also owns 3,514 shares of Angion Biomedica Corp (ANGN) as of December 20, 2021, with a value of $35,140 and a weighting of 6.59%.

Latest Holdings of John F. Neylan

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
KERX Keryx Biopharmaceuticals Inc 2018-11-15 148,279 3.36 498,217
ANGN Angion Biomedica Corp 2021-12-20 3,514 10.00 35,140

Holding Weightings of John F. Neylan


John F. Neylan Form 4 Trading Tracker

According to the SEC Form 4 filings, John F. Neylan has made a total of 0 transactions in Keryx Biopharmaceuticals Inc (KERX) over the past 5 years. The most-recent trade in Keryx Biopharmaceuticals Inc is the sale of 1,156 shares on November 15, 2018, which brought John F. Neylan around $3,202.

According to the SEC Form 4 filings, John F. Neylan has made a total of 9 transactions in Angion Biomedica Corp (ANGN) over the past 5 years, including 0 buys and 9 sells. The most-recent trade in Angion Biomedica Corp is the sale of 36 shares on December 20, 2021, which brought John F. Neylan around $938.

Insider Trading History of John F. Neylan

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

John F. Neylan Trading Performance

GuruFocus tracks the stock performance after each of John F. Neylan's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by John F. Neylan is -24.3%. GuruFocus also compares John F. Neylan's trading performance to market benchmark return within the same time period. The performance of stocks bought by John F. Neylan within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how John F. Neylan's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of John F. Neylan

Average Return

Outperforming Transactions

Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -27.4 -24.3 -46.9 -33.52 -0.31 -20.24
Relative Return to S&P 500(%) -21.41 -22.38 -36.29 -38.2 -8.49 -30.99

John F. Neylan Ownership Network

Ownership Network List of John F. Neylan

No Data

Ownership Network Relation of John F. Neylan


John F. Neylan Owned Company Details

What does Angion Biomedica Corp do?

Who are the key executives at Angion Biomedica Corp?

John F. Neylan is the See Remarks of Angion Biomedica Corp. Other key executives at Angion Biomedica Corp include director & See Remarks Jay Venkatesan , See Remarks Gregory S Curhan , and See Remarks Jennifer J Rhodes .

Angion Biomedica Corp (ANGN) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Angion Biomedica Corp (ANGN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Angion Biomedica Corp (ANGN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Angion Biomedica Corp (ANGN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Angion Biomedica Corp Insider Transactions

No Available Data

John F. Neylan Mailing Address

Above is the net worth, insider trading, and ownership report for John F. Neylan. You might contact John F. Neylan via mailing address: 750 Lexington Avenue, New York Ny 10022.

Discussions on John F. Neylan

No discussions yet.